Atlas Trials

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Clinical trial NCT05975151 · UNKNOWN

Trial details

NCT number
NCT05975151
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2023-10-01
Primary completion
2025-08-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.